$NVST

Envista Holdings Corp

Envista is a global dental products company serving dental professionals in over 130 countries, including specialists, general dentists, dental laboratories, dental service organizations, and other oral health providers. It operates through two segments: Specialty Products & Technologies, which includes dental implants and orthodontics, and Equipment & Consumables, which includes diagnostic and consumable dental products. Its brands include Nobel Biocare, Ormco, DEXIS, and Kerr. Envista develops, manufactures, and markets dental implant systems, prosthetics, orthodontic products, imaging equipment and software, restorative and endodontic products, infection prevention supplies, and other dental tools. It sells directly to dental professionals and through distribution partners. Sales of consumable products, services, and spare parts comprised approximately 85% of its 2025 sales. Envista is headquartered in Brea, California.

AlphAI earnings readThird Quarter 2026 · NOV 4Envista Reports Third Quarter 2026 ResultsVerdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

No enriched coverage for $NVST in the last 7 days.

No SEC Form 4 filings for $NVST in the last 30 days.

See all $NVST insider activity →
Med

Envista Announces Pricing of $430 Million of Senior Notes

Envista Holdings Corporation (NYSE: NVST) priced a $430 million offering of 6.250% Senior Notes due 2033 at 99.482% of the principal amount. The offering is expected to close by November 24, 2026. Proceeds will repay a term loan and cover general corporate purposes. J.P. Morgan, BofA Securities, and Wells Fargo Securities are active bookrunners.

Envista Q3 Earnings Call Highlights '26 Guidance Raise & China Risks

Envista Holdings (NVST) raised its 2026 earnings outlook, reporting Q3 adjusted EPS of $0.40 (beating estimates) and revenue of $691.5M. Growth was driven by productivity and pricing, but China's VBP reforms may pressure 2027 margins. NVST expects continued margin expansion and product commercialization.

NVST sentiment & insider activity

Recent NVST coverage spans financial news, earnings and corporate actions.

What's driving NVST

AlphAI scores every news story that mentions NVST with an AI model for sentiment and relevance, and aggregates insider trades from Envista Holdings Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NVST

Score
$NVSTMedAI 8/10Debt financing· $430M

Envista Announces Pricing of $430 Million of Senior Notes

Envista Holdings Corporation (NYSE: NVST) priced a $430 million offering of 6.250% Senior Notes due 2033 at 99.482% of the principal amount. The offering is expected to close by November 24, 2026. Proceeds will repay a term loan and cover general corporate purposes. J.P. Morgan, BofA Securities, and Wells Fargo Securities are active bookrunners.

$NVSTHighAI 8/10Earnings

Envista Reports Third Quarter 2026 Results

Envista Holdings (NYSE: NVST) reported Q3 2026 sales of $691M, up 2.7% year-over-year. GAAP EPS was $3.11, adjusted EPS $0.40. Adjusted EBITDA grew 9% to $106M. The company raised full-year guidance, citing strong momentum. It repurchased 386K shares for $10M and has $273M remaining in its buyback program.

Envista earnings in focus: China headwinds test dental recovery

Envista Holdings Corp. reports Q3 earnings, with analysts expecting $0.36 EPS on $688.8M revenue, down from Q2 due to China's orthodontic procurement policies. Full-year guidance remains unchanged. Analysts maintain a Buy rating with a $28.69 price target, but recent downgrades cite China headwinds. Investors will watch for commentary on China's impact and margin trends.

Envista Announces Release of 2025 Sustainability Report

Envista Holdings Corporation (NVST) released its 2025 Sustainability Report, highlighting progress in dental care access, employee support, environmental efficiency, and governance. Key achievements include a 40% reduction in waste, 19% reduction in water use, $2.4M donated to the Envista Smile Project, and a 17% decrease in lost time injuries. The report outlines performance and future improvement opportunities.

Related tickers